1. Home
  2. PACB vs GLRE Comparison

PACB vs GLRE Comparison

Compare PACB & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • GLRE
  • Stock Information
  • Founded
  • PACB 2000
  • GLRE 2004
  • Country
  • PACB United States
  • GLRE Cayman Islands
  • Employees
  • PACB N/A
  • GLRE N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • GLRE Property-Casualty Insurers
  • Sector
  • PACB Industrials
  • GLRE Finance
  • Exchange
  • PACB Nasdaq
  • GLRE Nasdaq
  • Market Cap
  • PACB 568.0M
  • GLRE 486.3M
  • IPO Year
  • PACB 2010
  • GLRE 2007
  • Fundamental
  • Price
  • PACB $1.64
  • GLRE $14.12
  • Analyst Decision
  • PACB Buy
  • GLRE
  • Analyst Count
  • PACB 13
  • GLRE 0
  • Target Price
  • PACB $2.92
  • GLRE N/A
  • AVG Volume (30 Days)
  • PACB 9.1M
  • GLRE 83.9K
  • Earning Date
  • PACB 02-13-2025
  • GLRE 03-04-2025
  • Dividend Yield
  • PACB N/A
  • GLRE N/A
  • EPS Growth
  • PACB N/A
  • GLRE N/A
  • EPS
  • PACB N/A
  • GLRE 2.53
  • Revenue
  • PACB $173,147,000.00
  • GLRE $702,254,000.00
  • Revenue This Year
  • PACB N/A
  • GLRE N/A
  • Revenue Next Year
  • PACB $21.56
  • GLRE N/A
  • P/E Ratio
  • PACB N/A
  • GLRE $5.58
  • Revenue Growth
  • PACB 2.14
  • GLRE 8.96
  • 52 Week Low
  • PACB $1.16
  • GLRE $11.01
  • 52 Week High
  • PACB $7.50
  • GLRE $15.82
  • Technical
  • Relative Strength Index (RSI)
  • PACB 37.69
  • GLRE 51.61
  • Support Level
  • PACB $1.59
  • GLRE $13.42
  • Resistance Level
  • PACB $2.22
  • GLRE $14.31
  • Average True Range (ATR)
  • PACB 0.17
  • GLRE 0.29
  • MACD
  • PACB -0.04
  • GLRE 0.06
  • Stochastic Oscillator
  • PACB 7.94
  • GLRE 78.65

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed, and income from investments.

Share on Social Networks: